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Abstract: With advances in intensive supportive therapy and multi-disciplinary Cystic fibrosis (CF) 
care, life expectancy in CF has markedly increased over the last decade. Exercise testing has evolved as 
an integral part in CF patient management. Indeed, exercise testing includes the assessment of 
functional capacity and morbidity; however, it is also essential in demonstrating the effects of therapy 
and training programs. Moreover, regular exercise training can improve aerobic and anaerobic 
capacity, increase inspiratory muscle strength and enhance airway mucus clearance. Nevertheless, in 
spite of the beneficial effects of regular physical activity, standardized exercise testing followed by 
structured training is rather uncommon among CF clinicians. Reviewed in the present study are the 
most common field and laboratory exercise tests available in the healthcare of children and 
adolescents with CF. 
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Introduction 
Exercise testing in Cystic fibrosis (CF) is gaining clinical interest as an important tool 
to assess disease severity and functional ability. Furthermore, exercise testing has 
been used as an outcome measure of therapy and exercise programmes, as well as 
for prognostic purposes (1-6). It has been established, that aerobic and anaerobic 
capacity is reduced in most patients with CF when compared to their healthy 
counterparts, with impaired respiratory function and malnutrition being likely 
contributing factors (7-10). It has also been documented that children with CF with 
higher activity levels have a better aerobic and anaerobic fitness and nutritional 
status, and a significantly lower disease severity (11). Moreover, higher aerobic 
fitness is associated with a higher health-related quality of life (11;12). Aerobic and 
anaerobic training has been shown to improve peak oxygen consumption 
(peak 2OV
 ), to enhance airway mucus clearance and to increase muscle mass, 
resulting in weight gain (3;13-16). In CF, aerobic capacity and training has received 
greater attention than anaerobic training. However, children‟s natural activity patterns 
are predominantly anaerobic, as opposed to aerobic. 
Pulmonary function testing (PFT) at rest is widely used and an important tool to 
assess the severity of lung disease, although PFT cannot accurately predict a 
patient‟s exercise capacity (17;18). A combination of PFT, exercise testing and 
quality of life assessment may be better tools to evaluate a patient‟s overall health 
status (12).  
Apart from laboratory exercise testing, simple field tests have been used to assess 
exercise tolerance and to determine the effects of therapeutic interventions in 
children with CF. In terms of validity, precision and objectivity, cardiopulmonary 
exercise testing (CPET) is considered the gold standard to assess a patient‟s 
exercise capacity and organ-specific function. As observed by Barker et al, exercise 
*Manuscript (All Manuscript Text Pages, including References and Figure Legends - No Author Information)
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 2 
testing is clinically important, even though clinicians do not generally use CPET as 
part of their routine examination. Field exercise testing may be the preferred choice, 
due to time constraints, lack of expertise, equipment and staff, and funding (19). 
Ideally, clinicians should encourage their patients to be physically active in their daily 
life as inactivity leads to further deconditioning. Therefore, exercise testing is vital in 
the provision of safe and effective training recommendations. The aim of the present 
study was to provide a review of field and laboratory exercise tests available to 
children and adolescents with CF.  
 
Method of review 
All relevant studies for this review were identified using electronic search of Medline® 
and PubMed® databases between the years 1958 and 2008. A bibliography search of 
all accessed publications was also performed. Key descriptors were Cystic fibrosis, 
exercise testing, aerobic fitness, children and adolescents. Two of the four authors 
(TR, DS) independently pre-selected relevant studies to be included in this article. 
The further selection of studies presented in the review was based upon the 
agreement of all four authors. We included studies of subjects with CF, independently 
of their disease severity, and type of physical training (aerobic training; anaerobic 
training; combination of aerobic and anaerobic training, as well as, inspiratory muscle 
training). As there is a lack of longitudinal studies on exercise training in children and 
adolescents with CF, the authors believe that there are too small a number of 
randomized controlled trials to allow a systematic Cochrane review. However, the 
authors propose that it is justified to include studies of shorter duration, different 
study designs and non-randomized controlled trials. We aim to provide a review on 
clinical exercise testing in children and adolescents with CF. This article is intended 
to be comprehensive, however, not exhaustive.  
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A. Field tests  
1. Assessment of breathlessness 
In CF patients, breathlessness is a common clinical symptom during physical 
exertion. Breathlessness is a subjective sensation, not necessarily associated with 
clinical symptoms such as wheezing or cough. However, breathlessness is often 
associated with fear and panic, resulting in reluctance to partake in physical activity. 
Depending on the pulmonary disease severity, dyspnoea can occur during exercise 
or even at rest. Several tools are available to quantify breathlessness during exercise 
testing; yet, measures of perceived breathlessness are not always well understood 
by children, and, therefore, need to be interpreted carefully. Both the modified Borg 
Scale of perceived breathlessness and the visual analogue score (VAS), are 
subjective measures to assess breathlessness. The original Borg Scale of perceived 
exertion was modified to assess perceived breathlessness during exercise (20). The 
patient is asked to rate his feeling regarding shortness of breath, using a rated scale 
(0 = no breathlessness at all; 10 = breathlessness at rest). The VAS consists of a 100 
mm horizontal line anchored with word descriptors at each end. The patient is asked 
to mark horizontally through the line according to their actual perception of 
breathlessness, starting on the left (zero), labelled as „I am not at all short of breath‟ 
to „The most short of breath I have ever been‟ at the other end. The distance 
between the zero point and the mark is measured (mm). In contrast to subjective 
assessments of breathlessness, the fifteen-count breathlessness score aims to 
objectively evaluate breathlessness, a method that has also been tested in children 
with CF (21). The patient has to take a deep breath in while counting out loud to 15 in 
8 seconds. The number of breaths required to complete the count, including the initial 
one, amount to the final score. The minimum score is, therefore, one. Most clinical 
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 4 
studies in children with CF use combinations of subjective and objective measures of 
breathlessness.  
 
2. Six-Minute Walk Test 
The 6-minute walk test (6-MWT) has been modified from the original 12-minute 
running test and the 12-minute walking test to assess the physical capacity of 
individuals (22;23). The 6-MWT is a practical and simple test, which primarily 
measures the distance a patient can quickly walk during six minutes. Walking is a 
daily activity; therefore, the 6-MWT is easy to perform. The test should be undertaken 
indoors, ideally along an enclosed corridor with a hard and flat surface. Most studies 
have used corridors with a length between 20 and 50 meters; however, there is no 
effect on the length of straight courses (24). The turnaround points as well as a 
starting line are marked with cones or coloured tape placed on the floor. A stopwatch 
is required to monitor testing time; turnarounds must be recorded to measure the 
covered walking distance. While the 6-MWT is self-paced, it is generally 
recommended not to walk alongside the patient. However, the practical use and 
application at individual centers seems to be different in daily clinical practice. 
According to our clinical experience, children might require verbal encouragement 
while performing the test to ensure maximum efforts. If the operator walks with the 
patient, it is required to stay behind him/her to avoid influencing the patients walking 
speed. Furthermore, in terms of standardization, we recommend that the test is 
ideally supervised and controlled by the same supervisor, particularly, if tests are 
performed longitudinally for comparison. If the patients walk alone, they can carry a 
portable pulse oximeter.  
It has been documented that the 6-MWT is useful and reproducible in patients with 
respiratory disease, for whom a 12-minute walk test is too exhausting (25). In healthy 
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 5 
children, the 6-MWT has been shown to be highly acceptable and valid, with a 
significant correlation between the walking distance and peak 2OV
  during an 
incremental treadmill exercise test (26-28). Normative values for healthy children 
have been briefly published (27). However, normative values for children with CF are 
not available. Several investigators have described the 6-MWT as useful and 
valuable in assessing exercise tolerance in CF children and adults with mild to 
moderate lung disease (29-31). Gulmans et al found a high correlation between the 
walking distance for two walking tests in each individual (31). Furthermore, a 
significant correlation was determined between the walking distance and maximal 
power (watts) or peak 2OV
  obtained during incremental cycle ergometry testing. It is 
important to emphasize that the 6-MWT, as a self-paced test, is dependent on the 
patient‟s motivation and has a tendency for sub-maximal efforts. More studies are 
needed to obtain information about its validity, including larger numbers of children 
with CF at different stages of disease severity. 
 
3. Shuttle tests 
Shuttle walking tests are incrementally and externally paced exercise tests, which 
can be performed as a 12-level or the modified 15-level shuttle test. Bradley et al 
showed that the modified shuttle walking test (MSWT) is a reliable and sensitive 
measure of exercise capacity in adults with CF (32). Twelve patients performed two 
MSWT within two weeks, revealing a high correlation between distance walked, peak 
heart rate (peakHR), oxygen saturation (SaO2) and perceived breathlessness. The 
MSWT incorporates a walk or run back and forth on a 10-m course marked with 
cones, with an increased speed every minute by a pre-recorded audio signal. The 
test ends when the patient is unable to keep the set pace or by the operator if the 
patient is no longer able to complete a shuttle in the given time (0.5-1.0 meter 
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 6 
distance away from the cone, depending on the set guidelines). In children with CF, 
the usefulness of the MSWT to measure exercise capacity and determine clinical 
improvement after hospitalization has been shown (33). Selvadurai et al compared 
two shuttle tests (10 m shuttle walk and 20 m shuttle run) with the results from 
treadmill exercise testing in CF patients with a wide range of disease severity, 
showing that both tests are reproducible and valid measures of exercise tolerance. 
Moreover, the authors reported a high correlation between the distance walked and 
measured peak 2OV
  values (34). Furthermore, the MSWT is useful in estimating 
peak aerobic capacity. In a recent study, Coelho et al demonstrated no differences in 
distance walked between healthy and CF children with normal lung function and mild 
to moderate symptoms, while healthy controls showed significantly higher ratings of 
perceived exertion (RPE) using the Borg Scale (35). The MSWT requires less space 
and is an inexpensive and appropriate alternative measure in comparison to CPET in 
children with CF.  
 
4. Three-Minute Step Test 
The 3-minute step test (3-MST), modified from the original „master two-step exercise 
test‟ has been used in children with CF as an outcome measure of intravenous 
antibiotic treatment, to assess exercise capacity and symptomatic exercise tolerance, 
and to evaluate candidates for lung transplantation (36-39). The test is externally 
paced and thus not influenced by motivation. Subjects are instructed to step up and 
down on a commercially available step, set at a height of 15 cm. The step frequency 
is kept constant at a pace of 30 steps per minute for 3 minutes, controlled by a 
metronome and the testing time recorded by a stopwatch. Furthermore, to reduce 
localized muscle fatigue, patients should be instructed to change the leading leg 
during the test. In case of a prematurely terminated test due to muscle fatigue or 
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breathlessness, the number of steps taken must be added up. In terms of the test‟s 
validity, results of the 3-MST may be influenced by leg length of each individual. Thus 
to enhance validity, the bench height should be adjusted individually according to the 
subjects leg length (40). This issue is important if test results are interpreted; in 
particular, if longitudinal data of individuals are compared. As examined by Narang et 
al, the 3-MST is limited in its validity if applied to children with mild lung disease, due 
to its low intensity. Compared with an incremental exercise test to exhaustion, 
clinically relevant information such as exercise induced arterial oxygen desaturation 
may be missed using the 3-MST. However, compared to a 6-MWT, the 3-MST 
produces a significantly higher heart rate (HR) and breathlessness score, without any 
differences in SaO2 (37;38). However, the 3-MST is easy to perform and requires 
little space. It does not, however, reflect a normal functional task and is also not able 
to measure aerobic capacity in patients with CF. 
 
5. Modified Munich Fitness Test 
 
The modified Munich Fitness Test (mMFT) has been adapted from the Munich 
Fitness Test (41). The original version is a well known and widely accepted test that 
was developed to assess physical fitness of school children at the age of 6 to 18 
years. The mMFT includes the following four test-tasks:  
1. balancing and bouncing: standing on a beam and bouncing a ball with 
both hands as fast as possible within 30s. The total number of correctly 
performed bounces is measured and implies the score.  
2. accurate throw: a 500g bean bag has to be thrown to five target fields 
with a distance of 3m away from the throwing line. Each field has a certain 
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 8 
number (1-2-3-2-1). For the score, the number of five correctly performed 
attempts is summed. 
3. trunk flexibility: standing on a beam, keeping feet one‟s together and 
reaching forward from the standing position with knees straight. The best of 
two attempts is scored (in cm).  
4. standing vertical jumping: jumping as high as possible from the standing 
position with bended knees. The difference between standing reach-high 
and jump-and reach-high of two attempts is measured (in cm).  
 
The individual testing results enable comparisons to a normative standard. Detailed 
instructions of the test are available at: “www.sportunterricht.de” (in German only). 
The only study, including the mMFT was performed in a large group of 286 children 
and adolescents with mild to moderate CF lung disease (6-18 years of age) during a 
4-6 week inpatient rehabilitation. In comparison to healthy children, test scores of 
children with CF were lower, however within the normal range. Improvements were 
seen in all test tasks after an inpatient training regime. Gruber et al showed that the 
mMFT is a valid and useful tool to assessing several components of physical fitness 
including endurance capacity, flexibility, balance and motor skills in children with CF 
(42).  Most other studies focus solely on increased aerobic fitness (peak 2OV
 ) or 
muscular strength of a certain muscle group, which are obviously clinically relevant 
parameters. However, the mMFT provides additional information regarding physical 
fitness as well as components of motor performance in children and adolescents with 
CF. Furthermore, individual limitations can be detected during testing and improved 
through a special training program. Thus, due to improved motor skills, activities of 
daily life could be implemented more easily. There is a need of more studies to obtain 
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 9 
more information regarding the validity and reliability of the mMFT, including patients 
with CF with a wider range of lung disease severity.  
 
Summary 
All field exercise tests discussed have shown to be useful when working with children 
and adolescents with CF. All the above field tests can be combined with different 
measurements, summarized in Table 1, solely the mMFT. This test is not appropriate 
to assessing aerobic fitness or provoking symptomatic exercise tolerance in CF. 
However, each test incorporates specific advantage and disadvantage. In 
comparison, the shuttle-walk test has a stronger correlation with oxygen consumption 
( 2OV
 ) than the 6-MWT. The 6-MWT is self-paced and has, therefore, been shown to 
be sub-maximal in its effort. In particular, compared to the step test, the 6-MWT relies 
more on patient motivation. In contrast, the step test may miss out important clinical 
information in patients with mild to moderate CF lung disease, due to its low intensity. 
The mMFT is easy to perform, provides important information for the clinician and is 
a useful tool to measure improvements of training programs. Further research is 
needed including patients with more advanced lung disease, while this test has only 
been established in children and adolescents with normal and mildly impaired lung 
function. In children with CF, the choice of each field test should be adapted for each 
individual subject according to the child‟s ability and disease severity.  
 
B. Laboratory exercise tests  
Laboratory exercise testing is usually performed on a cycle ergometer or treadmill in 
children and adolescents with CF. Depending on the disease severity, equipment 
and the clinical experience of the examiner, a choice of different tests is available. 
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Different tests measuring aerobic and anaerobic responses to exercise in children 
with CF are discussed below.  
 
1. Sub-maximal exercise tests 
Sub-maximal exercise testing may be a preferred method for patients who are not 
able to perform a maximal exercise task. Barry and Gallagher reported repeated sub-
maximal exercise tests on the cycle ergometer (80 % of peak workload) as a suitable 
technique to assess therapeutic benefits in adults with CF (43). In a three-month 
supervised running program and a 12-month unsupervised exercise training program, 
HR at sub-maximal workloads significantly decreased as a result of improved cardio-
respiratory fitness (3;44). Recently, 2OV
  kinetics in CF has been investigated. 
Hebestreit et al reported slower 2OV
  kinetics at the onset of exercise in children with 
CF compared to healthy children (45). However, kinetics protocols are not considered 
as practical in daily clinical care as they are laborious and require three to four 
repeated tests, and, therefore, regarded rather as a research tool. As shown, sub-
maximal exercise testing is thus more valuable to determine benefits of training 
programs. However, to detect limiting factors, maximal exercise testing is a preferred 
method.  
 
2. Maximal exercise tests 
Maximal exercise testing can be performed on the cycle ergometer or treadmill 
combined with online analysis of expired air. In children, measurements of peak 2OV
 , 
during an incremental exercise test to exhaustion, is widely recognized as the best 
single index of a child‟s cardiopulmonary fitness. The most frequently used protocols 
for children with CF are the „Godfrey protocol for cycle tests‟ and the „Bruce protocol 
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for treadmill testing‟ (46;47). Godfrey‟s cycle protocol starts with a workload of 0 watts 
for two minutes, with the work load being increased by 10, 15 or 20 watt increments, 
depending on the patient‟s height (<120 cm 10 watt; 120-150 cm 15 watt, >150 cm 
20 watt). The choice of protocol also depends on the physical fitness, disease 
severity and an adequate testing time. Bruce‟s protocol for treadmill testing starts at a 
speed of 1.7mph and an incline of 10%. At three-minute intervals, the incline 
increases by 2% and the speed by 2.7 mph, 3.4 mph, 4.2 mph, 5.0 mph, 5.5 mph, 
6.0 mph, 6.5 mph, 7.0 mph, and 7.5 mph, respectively, until exhaustion (46). 
Advantages of a cycle ergometer test are the reduced risk of injuries, an accurate 
and more comfortable record of additional parameters such as electrocardiogram, 
blood pressure, and SaO2. Apart from financial implications and space requirements, 
the treadmill test is particularly applicable for younger patients. Furthermore, higher 
maximum values for oxygen consumption are obtained (up to 10 %) compared to 
cycle testing, due to the higher amount of muscle mass involved. In CF, there are 
many indications for CPET .  
 
Studies have shown the usefulness of peak 2OV

 testing for prognostic purposes, and 
investigators have also documented high correlations between aerobic capacity and 
quality of life (1;2;4;12). Nixon et al also reported a positive association between 
aerobic capacity (peak 2OV
 ) and survival in CF over an extended period of eight 
years (2). In another longitudinal observation of 28 children with CF between 8 to 17 
years of age, a correlation between forced expiratory volume in 1 sec (FEV1) and 
peak 2OV
  was found. Furthermore, the decline in FEV1 was correlated with the 
change in peak 2OV
  in individuals over a five year period (4).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 12 
Several training studies have shown improvements in aerobic fitness regardless of 
methodological differences in training parameters obtained (duration, intensity, 
frequency) and type of exercises (3;15;48;49). Unfortunately, fewer longitudinal data 
are available to support beneficial effects of regular physical activity (PA). In a recent 
study the relationship between PA and aerobic fitness (peak 2OV
 ) was investigated in 
CF patients (12-40 years of age) with a wide range of pulmonary disease severity 
(FEV1 25–107% predicted) (50). The study revealed a significant relationship 
between PA and peak 2OV
 , independently of other variables such as body size, sex, 
lung function and muscle power.  
 
3. Wingate Test 
The Wingate Anaerobic Test (WAnT) is the most thoroughly investigated and applied 
test to assess maximal anaerobic performance in healthy children, as well as children 
with CF and other chronic disease (11;51-56). The WAnT is a 30 s all-out sprint test 
against a pre-determined resistance on an electrically braked cycle ergometer set in 
a constant torque. The test measures the ability of a group of muscles to perform 
short supra-maximal tasks, measuring peak muscle power and muscle endurance 
(peak power, mean power, and fatigue index). Usually a warm-up (3-5 min) is 
performed including a few sprints (3-5 s) to get the subject familiarized with the test 
procedure. Detailed information regarding the test protocols is described elsewhere 
(51;57). When comparing CF and healthy children, their anaerobic capacity is 
reduced (7;52-54;58). Peak and mean power (watts) is lower in CF patients in 
correlation to percent fat-free mass, rather than body mass (7;10;56). Other factors 
which may affect anaerobic performance in CF are CF genotype and maturational 
status (7;59). Boas et al investigated energy metabolism during anaerobic exercise in 
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children with CF and proposed that lower percentages of peak 2OV

 and peak 
ventilation (peak EV
 ) during the WAnT may be used compared to asthmatics and 
healthy controls. This is most likely mediated by a greater use of glycolytic 
metabolism in CF (52). Studies have also suggested that nutritional status is one of 
the main determinant affecting anaerobic performance (7;10;53). In contrast, Cabrera 
et al studied CF patients with a wide range of pulmonary disease severity and 
showed a negative relationship between impaired pulmonary function and anaerobic 
performance. The authors reported, anaerobic performance during the WAnT 
depends highly on anaerobic metabolism in the exercising muscle, and is thus largely 
independent on the oxygen transport system (53). However, this finding may not be 
significantly associated with the degree of lung function impairment and anaerobic 
capacity as measured by WAnT. Furthermore, the WAnT has also shown to be useful 
as an outcome measure for training studies. Klijn and colleagues showed significant 
improvements in both aerobic and anaerobic WAnT parameters following a 12-week 
individualized anaerobic training program (2 days per week, 30-45 min). After a 12-
week follow-up period, most outcome parameters decreased compared to pre-
training levels, except of anaerobic performance and quality of life (13). Moreover, CF 
children with higher levels of habitual activity have been found to possess increased 
anaerobic power during the WAnT and quality of life (11). More research is required 
in this field, in particular using training studies, to provide more detailed 
recommendations for exercise programs.  
 
Safety instructions and contraindications 
In general, specific safety guidelines have to be followed, particularly when children 
are involved. Therefore, resuscitation equipment and trained personnel have to be 
available. Compared to healthy children, CF children are at a higher risk of cardio-
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respiratory compromise during exercise (e.g. hypoxemia, bronchoconstriction, and 
pneumothorax). During laboratory exercise testing, the continuous monitoring of HR 
and SaO2 during the test is indicated. Any exercise stress test should be terminated if 
the SaO2 drops below 75 % as previously recommended (37;38;60). If supplemental 
oxygen is required during an exercise test, clinical details need to be documented, 
and the amount of supplemental oxygen kept constant during and immediately after 
the exercise test. More detailed information regarding the absolute and relative risks 
as well as contraindications of exercise testing in children are described elsewhere 
(18;61). 
 
Conclusion 
Exercise testing is regarded an important prognostic tool in CF care. However, 
despite its beneficial effects, clinical exercise testing seems underused. Clinicians 
and their staff should encourage patients with CF to be physically active and 
recommend exercise testing to patients ideally once a year as it is already practiced 
in several countries. We conclude that, if no laboratory testing is available, field tests 
are an inexpensive and valid alternative. Nevertheless, field exercise testing is often 
crude and unable to detect exercised-induced limitations, which are common in 
patients with pulmonary disease. Furthermore, the measurement of peak 2OV
  is 
correlated with lung function and appears to be a valuable predictor of disease 
progression in CF. The use of laboratory exercise testing may be limited by cost and 
equipment, as well as time and personnel. In our experience, patients have to be well 
instructed regarding the test procedure, and the clinician and the CF team should be 
encouraged to create a positive environment, whenever possible.  
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Table  
Table 1 Measurements obtained during field testing 
 
Abbreviations 
CF = Cystic fibrosis 
peak 2OV
  = peak oxygen consumption 
PFT = Pulmonary function testing  
CPET = Cardiopulmonary exercise testing 
VAS = Visual Analogue Score 
6-MWT = Six-Minute Walk Test 
MSWT = Modified Shuttle Walk Test 
peak HR = peak Heart rate 
SaO2 = Oxygen saturation 
RPE = Ratings of perceived exertion 
3-MST = Three-Minute Step Test 
HR = Heart rate 
mMFT = modified Munich Fitness Test 
FEV1 = Forced expiratory volume in 1 s 
PA = Physical activity 
WAnT = Wingate Anaerobic Test 
peak EV
  = peak Ventilation 
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Table 1 Measurements obtained during field testing 
 
Measurements 
 
Three-Minute Step Test Six-Minute Walk Test Shuttle Test 
Spirometry 
 
pre and post 
 
pre and post pre and post 
Heart rate 
 
baseline and highest HR  or 
continuous recording 
 
baseline and highest HR or 
continuous recording 
baseline and highest HR or 
continuous recording 
Oxygen saturation   
 
baseline and lowest SaO2 or 
continuous recording 
 
baseline and lowest SaO2 or 
continuous recording 
baseline and lowest SaO2 or 
continuous recording 
Breathlessness 
 
Modified Borg Scale of Perceived 
Breathlessness; VAS; 15 Count 
Breathlessness Score 
Modified Borg Scale of Perceived 
Breathlessness; VAS; 15 Count 
Breathlessness Score 
Modified Borg Scale of Perceived 
Breathlessness; VAS; 15 Count 
Breathlessness Score 
Muscle fatigue 
 
Modified Borg Scale or Visual 
Analoque Score 
Modified Borg Scale or Visual 
Analoque Score 
Modified Borg Scale or Visual 
Analoque Score 
Set length of test [min] 3 
 
 
6 NA 
Table
Table 1 Measurements obtained during field testing « Continued » 
 
 
Distance  
 
NA 
 
Distance walked Distance walked 
 
Abbreviations: HR, Heart rate; NA, not applicable; SaO2, Oxygen saturation; VAS, Visual Analogue Score  
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recommendations provided. We have revised our manuscript accordingly and made 
the appropriate amendments in response to the Reviewer’s suggestions. We respond 
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independently of their disease severity, and type of physical training (aerobic training; 
anaerobic training; combination of aerobic and anaerobic training, as well as, 
inspiratory muscle training). As there is a lack of longitudinal studies on exercise 
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reproducibility, as well as own experiences on each of the different field tests. The 
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Abstract
Life expectancy in Cystic Fibrosis (CF) has markedly increased over the last few decades. 
This increase is partially due to the multidisciplinary approach in CF therapy and exercise 
testing which has established an important role for prognosis. Exercise not only encompasses 
the assessment of functional capacity and morbidity, but is also central to demonstrating the 
benefits from therapy and training programmes. Regular exercise training can improve the 
aerobic and anaerobic capacity, increase inspiratory muscle strength, and enhance mucus 
clearance in the airways. Despite the growing interest and due to the beneficial effects of 
regular physical activity, standardised exercise testing followed by structured training is not 
common among clinicians. The aim of this article is to review the most common field and 
laboratory exercise tests, used in CF. Furthermore, it includes a clinical case report and 
provides training recommendations which should be an efficacious part of every patient’s 
consultation.
Key words: pulmonary disease, exercise, aerobic fitness, training, physical activity
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2
Introduction
Exercise Testing in Cystic Fibrosis (CF) is gaining clinical interest as an important tool to 
assess disease severity, functional ability and has been used as an outcome measure of therapy 
and exercise programmes (1;2), as well as a prognostic measure (3-6). There is little doubt 
that aerobic and anaerobic capacity is reduced in CF individuals, when compared to their 
healthy counterparts (7-10). This reduction may be explained by an impaired lung function 
and malnutrition. It has also been established that CF children with higher activity levels have 
a better aerobic and anaerobic fitness, nutritional status and significantly lower disease 
severity (11). It is known that higher aerobic fitness is associated with higher quality of life 
(11;12). Consequently, aerobic and anaerobic training has been shown to improve peak 
oxygen consumption (peak 2OV ), enhances sputum clearance in the airways, increases 
muscle mass and results in weight gain (1;13-16). Aerobic capacity and training has also been 
given more attention than anaerobic training in CF children. This is paradoxical as children’s 
activity patterns are predominantly anaerobic in nature, as opposed to aerobic. Pulmonary 
function testing (PFT) at rest is widely used and an important tool to assess disease severity in 
patients with lung disease, but is not sufficient and accurate in predicting a patients exercise 
capacity (17;18). A combination of PFT, exercise testing and the assessment of quality of life 
may be a better outcome to assess the patient’s overall health status (12). Apart from 
laboratory testing, exercise tests, such as the three minute step test, six-minute walking test 
and the modified shuttle test have been used to assess exercise tolerance, determine the 
suitability for undergoing lung transplantation, as well as, an outcome measure of treatment 
and therapy programmes in CF children. In terms of validity, precision and objectivity, formal 
laboratory testing with continuous respiratory gas analysis are the best method to assess a 
patient’s exercise capacity. Therefore, from a clinical point of view, a test must be able to 
answer the questions of the clinician. As observed by Barker et al. (19) exercise testing is of 
clinical interest, even though clinicians do not use formal exercise tests as a routine 
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3
examination, because field tests are preferred. This may be explained by time constraints, a 
lack of equipment or expertise, staff and consumable costs. Clinicians should encourage their 
patients to be physically active in daily life because inactivity leads to further deconditioning 
in CF. Therefore, to provide safe and effective training and activity recommendations, 
exercise testing is necessary. The present paper aims to provide a review of field and 
laboratory exercise testing in CF children. Furthermore, an update on the aerobic and 
anaerobic response to exercise will be included and suggestions will be offered to the 
clinician with a special focus on peak 2OV testing, including practical training 
recommendations. 
Method of Review
All relevant studies for review were located through computer searches of Medline and 
PubMed databases between the years 1958 and 2008. This procedure was enhanced with a 
search for bibliographies of accessed publications. Key descriptors were exercise testing,
training, children, adolescents and cystic fibrosis (CF). One review article was found focusing 
on exercise testing in children with CF (20). The present review includes both, a summary of 
field exercise testing as well as laboratory exercise testing in CF, including a case report and 
recommendations for physical training.  
Field Tests
Three Minute Step Test
The 3-minute step test (3MST), modified from the original Master two-step exercise test, is 
externally paced and has been used in CF children as an outcome measure of intravenous 
antibiotic treatment (21), to assess exercise capacity (22), symptomatic exercise tolerance 
(23), and as a suitability for lung transplantation (24). As examined by Narang et al. (22) the 
test is limited in its validity when working with children with moderate lung disease, because 
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of its low intensity. Compared with an incremental exercise test to exhaustion, clinically 
relevant information e.g. exercise induced arterial oxygen desaturation may be difficult to 
detect during the 3MST. The 3MST compared to a 6-minute walking test, produces a 
significantly higher heart rate and breathlessness score (modified Borg breathlessness Score), 
without any differences in oxygen saturation (23). However, the test is quick to perform, 
requires less space, but doesn’t reflect a normal functional task and is not able to measure 
aerobic capacity. 
Six Minute Walk Test
The six minute walk test (6MWT) has been modified from the original 12 minute running test 
(25) and the 12 minute walking test (26) to assess the physical capacity in individuals. As the 
6MWT, it was shown to be useful and reproducible in patients with respiratory disease, for 
whom 12 minutes walking was too exhausting (27). In healthy children, the 6MWT has been 
revealed to be highly acceptable (28) and valid, as a significant correlation was established 
between the walking distance and 2OV max (r = 0.44) during an incremental treadmill 
exercise test (29). Several investigators found the test as useful and valuable in assessing 
exercise tolerance in CF children (30;31) and adults (32) with mild to moderate lung disease. 
Gulmans et al. (31) found a high correlation between the walking distance for two walking 
tests in each individual (r = 0.90). Furthermore, a significant correlation was determined 
between the walking distance and maximal power (watts) or 2OV max (r = 0.76) obtained in 
an incremental cycle ergometry test. The 6MWT as a self paced test is thus dependent on the 
patient’s motivation with a tendency for submaximal effort. More studies are desirable to 
obtain information about its validity, including larger numbers of children with different 
stages of disease severity.  
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Shuttle Tests
Shuttle walking tests are incrementally and externally paced informal exercise tests. They can 
be performed as a 12-level or the modified 15-level test. Bradley et al. (33) found the 
modified shuttle test (MST) is a reliable and sensitive measure of exercise capacity in adults 
with CF. Twelve patients performed two shuttle walking tests within two weeks and a high 
correlation was found between walk distance, peak heart rates, oxygen saturation (SaO2) and 
perceived breathlessness (r = 0.99). In children with CF the usefulness of the MST to measure 
exercise capacity and determine improvements after hospitalisation has been shown (34). 
Selvadurai et al. (35) compared two shuttle tests (10 m shuttle walk and 20 m shuttle run) 
with the results from treadmill exercise testing in CF patients with a wide range of disease 
severity and found both tests as reproducible and valid measures of exercise tolerance. 
Moreover, they reported a high correlation between the distance walked and measured peak 
2OV values (r = 0.91). Furthermore, the test is useful in estimating peak aerobic capacity. In 
a recent study Coelho et al. (36) found no differences in walk distance between healthy and 
CF children (p = 0.20) with normal lung function and mild to moderate symptomatology, 
while the healthy controls showed higher ratings of perceived exertion (RPE) using the Borg 
Scale (p = 0.007). The modified shuttle test requires less space and is an inexpensive and 
alternative measure to formal laboratory testing in children with CF. 
Summary
All the above mentioned exercise tests have shown to be useful when working with children 
and adolescents with CF. The tests can be combined with heart rate (HR) and oxygen 
saturation monitoring, RPE (Borg Scale) as well as breathlessness scores, e.g. the fifteen-
count breathlessness score or the visual analogue score of perceived breathlessness (22;37). In 
comparison, the shuttle walk test has a stronger correlation with 2OV than the 6MWT. The 
6MWT is self paced and has been shown to be submaximal in its effort. Compared to the step 
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test the 6MWT may rely more on patient motivation. In contrast as examined by Narang et al. 
(22) the step test may omit important and clinically essential information in patients with 
moderate lung disease, because of its low intensity. In CF children, the choice of each field 
test should be adapted for the individual according to the patient’s ability and disease severity. 
More detailed information about the testing instruction for the 6MWT, the MSWT and the 
3MST can be found elsewhere (23;38;39). 
Anaerobic Exercise Tests
Anaerobic activities are characterized by very heavy intensities lasting typically up to 30 s 
and are characterised as being predominantly fuelled by non-oxidative sources for ATP 
resynthesis e.g. sprinting to a bus or doing a double back flip. The predominant energy is 
produced by the high energy phosphates; Adenosine triphosphate (ATP) and Phosphocreatine 
(PCr) or through anaerobic glycolysis. Glycolysis is the anaerobic degradation of glucose to 
two molecules of pyruvate, due to 10 enzymatically controlled chemical reactions, with
lactate being formed as the end product of the anaerobic glycolysis. Further details can be 
found elsewhere (40;41).   
Wingate Test
The Wingate Anaerobic Test (WAnT) is the most researched and applied test to assess 
maximal anaerobic performance in healthy children, as well as CF and other chronically 
diseased children (11;42-47). The WAnT is a 30 s all-out sprint test against a predetermined 
resistance on a cycle ergometer and is used to determine peak muscle power and muscle 
endurance measuring the peak power, mean power and the fatigue index. Interested readers 
seeking further information should consult Bar-Or (42) and Dotan and Bar-Or (48). When 
comparing children with CF and healthy children, their anaerobic capacity is reduced 
(7;43;44;49). The peak and mean power (watts) was found to be lower in CF patients when 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
7
correlated to percent fat free mass, rather than body mass (7;10;47). Other factors which may 
affect anaerobic performance in CF are genotype of mutation and maturational status (7;50). 
Boas et al. (43) investigated energy metabolism during anaerobic exercise in CF children and 
proposed that they may use lower percentages of their peak 2OV and peak ventilation ( EV ) 
during the WAnT, compared to asthmatics and healthy controls. This finding is thought to be 
mediated by a greater use of glycolytic metabolism in the CF children. Further studies have 
suggested that nutritional status is the main determinant affecting the anaerobic performance 
(7;10;44). In contrast Cabrera et al. (44) studied CF patients with a wide range of disease 
severity and found a negative relationship between impaired pulmonary function and 
anaerobic performance. As the authors noted themselves, the anaerobic performance in the 
WAnT depends to a high degree on anaerobic metabolism in the exercising muscle, and thus 
is largely independent from the oxygen transport system. This finding may not be 
significantly associated with the degree of lung impairment and anaerobic capacity as 
measured by WAnT.  The WAnT also has shown to be useful as an outcome measure of 
training studies. Klijn and colleagues (13) found significant improvements in both aerobic and 
anaerobic (WAnT) parameters, after a 12 week individualised (2 days per week, 30-45 min) 
anaerobic training programme. After a 12 week follow up period, most outcome parameters 
decreased compared to the pre training level, except anaerobic performance and quality of 
life. Also, children with CF with higher levels of habitual activity have been found to have an 
increased anaerobic power in the WAnT and quality of life (11). More research would be 
beneficial in this field, especially in training studies, to provide more detailed 
recommendations during exercise programmes. 
Aerobic Exercise Tests 
Neither any physical activity nor exercise task can be considered as solely aerobic or 
anaerobic. However, aerobic activities refer to the predominant use of oxygen in the energy-
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generating process. Typically, after ~90 s of maximal exercise, the oxidative contribution 
begins to dominant the resynthesis of ATP and exercise power or speed begins to decline. 
Oxidative metabolism begins with the entry of pyruvate in the mitochondria, a second stage of 
carbohydrate break down, namely the tricarboxylic acid cycle (TCA). This process is much 
slower, but possesses a greater capacity for energy generation than anaerobic pathways. 
Carbohydrates, free fatty acids (FFAs), amino acids and proteins all serve as energy releasers 
(40;41). Aerobic activities with moderate effort can be performed over hours without 
significant declines in exercise performance (although there is some variation on individual’s 
physical fitness, energy intake during exercise, outside temperature etc). Aerobic capacity of 
CF children over a long period of time is not known.
Submaximal Exercise Tests
Submaximal exercise testing may be preferred for patients who are not able to perform a 
maximal exercise task. Barry and Gallagher (51) reported repeated submaximal exercise tests 
on the cycle ergometer (80 % of peak workload) as suitable to assess therapeutic benefits in 
adult CF patients. In a three month supervised running programme (1) and a 12 month 
unsupervised exercise training programme (52), heart rates at submaximal workloads 
significantly decreased as a result of improved cardiorespiratory fitness. Research has also 
been recently investigated into the oxygen uptake ( 2OV ) kinetics in CF. Hebestreit et al. (53) 
found slower 2OV kinetics at the onset of exercise in CF children compared to healthy 
children. Although the kinetics protocols are laborious and require three to four repeat tests, 
which although interesting for further scientific related research are not considered practical 
in daily clinical practice. As shown, submaximal exercise testing is more valuable to 
determine benefits of training programmes. However, to detect limiting factors maximal 
exercise testing is necessary. 
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Maximal Exercise Tests
Maximal exercise tests can be performed on the cycle ergometer or treadmill combined with
online analysis of expired air. The most often used protocols are the Godfrey (54) for cycle 
tests and the Bruce (55) protocol for treadmill testing. The choice of each protocol depends on 
the anthropometric variables, age and disease severity. An essential advantage of a cycle 
ergometer test is the reduced risk of injuries, an accurate and more comfortable record of 
additional parameters such as electrocardiogram, blood pressure, and oxygen saturation. Apart 
from the financial cost and space requirement, the treadmill test allows testing younger 
patients, a higher maximum values will be obtained (up to 10 %) compared to cycle testing, 
due to the higher amount of muscle mass moved during treadmill testing.
In CF, there are many reasons for maximal exercise testing. Studies have shown the 
usefulness of peak 2OV testing as a prognostic value (3-5) and investigators have found high 
correlations between aerobic capacity and quality of life (12). Nixon et al. (4) also reported 
positive associations between aerobic capacity ( 2OV peak) and survival in CF patients over a 
period of eight years. Several training studies have shown improvements in aerobic fitness 
(1;15;56;57) despite methodological differences in the training parameters (duration, 
intensity, frequency) and type of exercises. Unfortunately, less longitudinal data are available 
to support beneficial effects of regularly physical activity on a long term basis. In a recent 
study Hebestreit et al. (58) investigated the relationship between physical activity (PA) and 
aerobic fitness ( 2OV max) in CF patients (12-40 years) with a wide range of disease severity 
(FEV1 25–107% predicted). The group report a significant relationship between PA and 
2OV max, but independently for other variables such as body size, sex, lung function and 
muscle power. 
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Especially when testing children, safety guidelines have to be strictly followed. During formal 
laboratory exercise testing the continuous record of HR and SaO2 during the test is useful not 
only for monitoring purposes but also in giving recommendations for training in CF. The 
exercise stress test should be terminated if SaO2 drops below 75 % as recommended by 
Hebestreit et al. (59) and adopted in several studies (22;23). As an additional objective 
method, the gas-exchange threshold (GET) can be determined due to the continuous analysis 
of 2OV and 2COV to estimate a threshold point (60). The following case report provides 
some practical applications for maximal exercise testing. These applications include the 
determination of baseline exercise capacity, to define exercise induced limitations, as well as 
to give safe and effective training recommendations.
Case Report 
Clinical Findings
This 17-year-old boy with CF was referred to the hospital for routine intravenous antibiotic 
treatment and physiotherapy.
Measurements
Functional Capacity 
The forced expiratory manoeuvre was performed according to the guidelines of the British 
Thoracic Society (61) using an electronic spirometer (Microloop ML3535; Numed, Sheffield, 
UK).
Maximal Exercise Testing
Maximal exercise testing was performed on an electronically braked cycle ergometer 
(Excalibur S port; Lode, Groningen, The Netherlands) using the Godfrey protocol (54). After 
a 2 minute warm up of unloaded pedalling, the work rate was increased by 10 W at 60 s 
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intervals until volitional exhaustion. The patient breathed through a mouthpiece from which 
ventilation ( EV ), oxygen consumption ( 2OV ) and carbon dioxide ( 2COV ) production was 
analysed using a computerized breath-by-breath system (Cortex Metalyzer; Cortex Medical, 
Leipzig, Germany). Oxygen saturation (SaO2) was monitored by a pulse oximeter (Tuffsat; 
Datex-Ohmeda, Colorado, USA). The ventilatory threshold was determined with the V-slope 
technique. Interpretation of aerobic fitness (peak 2OV ) was defined according to values 
described elsewhere (62).
Assessment of Disease Severity
The Shwachman score was used to assess disease severity and recorded prior to exercise 
testing (63). The score includes four separate parameters in the system (activity, physical 
examination, nutrition and chest radiographic findings). Each parameter has an assigned value 
of 25, while a hundred points represents a perfect score of health and reflects very accurately 
the patient’s long-term prognosis. 
Interpretation and Training Recommendations
This young patient has a severely impaired resting lung function (FEV1 36%, Table 1). The 
peak 2OV , maximum power as well as the threshold point are significantly reduced (Figure 1; 
Table 2;). The threshold point was determined at: a HR of 129 b.min-1; a work rate of 38 W 
and 42.7 % of peak 2OV , while the maximum HR of 184 b
.min-1 is reduced. During the 
incremental exercise test an arterial oxygen desaturation was determined, while SaO2 dropped 
down to 87 % at maximal effort. At maximal effort the patient exceeded his predicted MVV 
(Figure 1), which is a limiting factor caused by the increased ventilatory demand and the 
decreased capacity. Moreover, the crossing of the MVV is a typical sign of an insufficient 
ventilatory reserve. In this case, the absolute maximum power workload reached at the end of 
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the test was 89 W (1.58 W.kg-1.min-1), but the physical capacity is significantly reduced due 
the pathological arterial oxygen saturation and the reduced ventilatory reserve. Unfortunately, 
in this case SaO2 was not recorded continuously during the whole exercise test (only pre and 
post exercise SaO2), which is an essential parameter to define exercise induced limitations and 
to give accurate training recommendations. For these reasons, cycle ergometer training for 
example should not exceed the work load and/or HR related to SaO2 ≥ 90%, in order to 
prevent hypoxic conditions. The training parameters, such as HR (129 b.min-1) and power (38 
W) obtained at the threshold point can be used for training sessions, with the request of a 
continuous record of SaO2. In case of hypoxic conditions during training the power output has 
to be reduced, and/or resting periods increased. The low Shwachman score of 44 is congruent 
with the low functional capacity measured in this 17-y-old boy. Further training 
recommendations are discussed later in this article. 
General Guidelines for Exercise and Training
Medical Check Up
Before commencing exercise the CF patient should consult a medical doctor and be carefully 
examined and advised about training. Therefore, pulmonary function testing at rest is 
important but not sufficient, while the examination should also include maximal exercise 
testing to provide objective data, as functional capacity and to detect pulmonary and cardial 
limitations. On that basis, fundamental criteria of physical training, such as the type of 
activity, training methods, frequency, duration, and intensity can be specified. 
Exercise Training
The Clinical Guidelines for the Physiotherapy Management in the UK (64) support the fact 
that all patients with CF can exercise, while those with FEV1 > 55 % predicted are able to 
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exercise at the same level as their healthy peers. Patients with severe disease and FEV1 < 55 
% predicted should be carefully tested and supervised during exercise. 
Sports
When searching for sports the fun component should be the main consideration, but there are 
also some essential facts to be considered. We recommend performing different and varied 
activities, to improve endurance, strength, coordination and flexibility skills. As shown by 
Selvadurai et al. (15) exercise programmes including aerobic and anaerobic activities can be 
effective in improving muscle strength, lung function, quality of life and resulting in weight 
gain. Table 3 summarizes a selection of recommended exercises and activities with increased 
risk potential (e.g. pneumothorax) for the CF patient. Additional moderate strength training 
may include exercises for the whole body (arms, legs, back, and abdomen) with respect to the 
correct technical implementation and breathing work (expiration during contraction and 
inspiration during relaxation). The choice of each activity depends on the disease severity, 
social factors, time effort and the individual’s interests. Whenever possible, we recommend 
participating in team sports, which may increase motivation in the long term and support more 
social integration. Before starting team sports, the therapist should be well informed about the 
typical characteristics of the disease (e.g. increased cough during exercise), whilst the patient 
should be able to rest whenever rest is needed. Next to exercise training, an active lifestyle in 
general may help to improve exercise capacity, for example using stairs instead of an elevator.
Training Components
Regarding training recommendations the general guidelines for healthy individuals are valid 
and can be used and transferred for the CF patient. Physical training can be characterised due 
to the components: 
 intensity
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 duration
 frequency 
 type of activity
The proportion of training stimuli and recovery periods are essential to develop an 
individual’s physical capacity, whereas permanent training at high intensities for example will 
lead to performance stagnancy or even cause physical damage in the CF patient. Particularly, 
CF patients may need longer resting times to recover after exercise than their healthy 
counterparts. Further prolonged 2OV kinetics after maximal exercise were found in CF 
adults, which could be explained by deconditioning and the oxygen cost of breathing, caused 
by an increased dead space and total ventilation (8). Whereas, improvements in aerobic 
capacity can be observed after a relatively short time, after terminating training the effects 
will rapidly decrease to pre training level. Training components can be found in Table 3. 
Conventional formulas to determine maximal HR according to age, and calculate training 
intensities are insufficient because maximum heart rates are reduced in CF. Therefore, 
training intensities should be individually determined during maximal exercise testing. While, 
the GET is relatively reliable to determine, there is no need to take blood lactate samples in 
pediatric populations. Furthermore, as a helpful tool and to supervise training, ratings of 
perceived exertion (65) and/or the fifteen-count breathlessness score (37) can be applied. 
Precautions
Patients with advanced lung disease, and increased risk of arterial oxygen desaturation during 
exercise should continuously record their HR and SaO2 with a portable pulse oximeter and 
HR monitor. During exercise, SaO2 should be ≥ 90 % to prevent hypoxic conditions which 
may lead to a decrease in performance, increases pulmonary pressure and damages the heart 
function in long term. Additional oxygen supplementation during exercise at submaximal 
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work may avoid arterial oxygen desaturation as well as improve exercise performance in 
patients with advanced pulmonary disease (66-68). Patients with resting hypoxia (SaO2 < 90 
%) should generally exercise with additional oxygen supplementation. When suffering acute 
infections, patients should stop exercise and resume their training only after having consulted 
a medical doctor. Patients suffering CF related diabetes should be well trained about insulin 
dosages, the effects and risks of exercise (e.g. hypoglycaemia) and monitor their blood sugar 
levels in certain intervals. In order to prevent dehydration and excessive mineral loss (NaCl), 
sufficient fluids, ideally with higher salt contents, should be supplied during and after 
exercise, especially when exercising in hot environmental conditions (69;70). Moreover, 
children with CF may tend to underestimate their fluid loss during exercise and undergo the 
risk of excessive dehydration (69).  
Table 4 summaries possible effects of exercise and training studied in CF.  Unfortunately, few 
longitudinal data on the effects of exercise are available. Prolonged effects may also be 
complicated by the progressive character of the disease, less training possibilities during acute 
pulmonary exacerbations, motivation, as well as a certain sense of confidence to exercise with 
their healthy counterparts.
Conclusion
Exercise testing has shown to be valuable in the work with CF patients. Despite the beneficial 
effects of regularly exercise, clinical exercise testing is reported to be underused. Whenever 
possible, clinicians should include exercise testing as an additional diagnostic tool at least 
once a year as recommended in the UK. Moreover, it would be desirable to instruct patients 
about the beneficial effects of exercise and support them with effective training 
recommendations. Studies have shown that a combined training including aerobic and 
anaerobic activities may be most effective. Higher levels of habitual activity have been 
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associated with higher aerobic and anaerobic fitness, a better quality of life, as well as 
increased life expectancy. We conclude that, if no laboratory testing is available, field testing 
is an alternative, inexpensive and valid tool. Formal laboratory exercise testing may be limited 
by the cost and equipment, as well as the time and staff required in hospitals. Field exercise 
testing is more limited in detecting exercised induced limitations, which are essential in 
patients with pulmonary disease. With the experience of the authors, patients have to be well 
instructed about the testing procedure and the medical examiner needs to create a positive 
environment, whenever possible. 
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Figure Title
Figure 1. Physiological responses during a maximal incremental cycle test to voluntary 
exhaustion (MVV = Maximal voluntary ventilation)
Abbreviations
CF = Cystic Fibrosis
2OV = Oxygen Consumption
PFT = Pulmonary Function Testing 
3MST = Three Minute Step Test
6MWT = Six Minute Walking Test
MST = Modified Shuttle Test
SaO2 = Oxygen Saturation
RPE = Ratings of Perceived Exertion
HR = Heart Rate
MSWT = Modified Shuttle Walking Test
ATP = Adenosine Triphosphate
PCr = Phosphocreatine
WAnT = Wingate Anaerobic Test
EV = Ventilation
TCA = Tricarboxylic Acid Cycle
FFAs = Fatty Free Acids
PA = Physical Activity
FEV1 = Forced Expiratory Volume in 1 s
GET = Gas Exchange Threshold
2COV = Carbon Dioxide
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MVV = Maximum Voluntary Ventilation
NACL = Sodium Chloride
Figure
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Table 1 Patient Characteristics of the Case Study
Variable Measured Predicted (%)
Age, yr 17
Sex male
Height, cm 161
Weight, kg 56.4
BMI, kg/m2 21.5
Skinfold, mm 56.6
VC, L 2.17 52
FEV1, L 1.30 36
Resting SaO2, % 95
Shwachman Score 44
BMI = body mass index; VC = vital capacity; FEV1 = forced expiratory volume in 1s; SaO2 = oxygen 
saturation.
Table
Table 2 Peak Exercise Data
Variable Measured Predicted (%)
EV peak, L
.min-1 56.3
EV peak/predicted MVV, % 123.7
2OV peak, L
.min-1 1.39
2OV peak, mL
.kg-1.min-1 25.0 51%
AT/ 2OV peak, L
.min-1 0.69
EV / 2OV 40.5
EV / 2COV 33.6
RER 1.20
Wmax, W 89
Wmax, W/kg/BW 1.58
HRmax, b.min-1 190
SaO2,  % 87
EV = minute ventilation; MVV= maximum voluntary ventilation; 2OV peak = peak oxygen 
consumption; AT = anaerobic threshold; EV / 2OV = ventilatory equivalent for oxygen; EV / 2COV
= ventilatory equivalent for carbon dioxide; RER = respiratory exchange ratio; Wmax = maximum 
work load; HRmax = maximum heart rate.
Table
1Table 3 General Exercise and Training Recommendations
CF patients without pulmonary 
limitations and arterial oxygen 
desaturations
Patients with (severe) arterial 
oxygen desaturations and/or 
transplanted patients
Recommended activities cycling, walking, hiking, 
running, rowing, tennis, 
swimming, climbing and roller-
skating
ergometric cycling, walking,
strength training and 
gymnastics 
Method Intermittent and steady-state Intermittent 
Duration 30-45 minutes 20 minutes
Intensity 70-85% HRmax; 60-80% peak 
2OV ; LT; GET
60-80% HRmax; 50-70% peak 
2OV ; LT; GET
Frequency 3-5 times per week 5 times per week
Oxygen supplementation not  necessary permanent oxygen 
supplementation
Activities to avoid bungee-jumping, high diving 
and  scuba diving
bungee-jumping, high diving, 
scuba diving and hiking in high 
altitude
HRmax = maximum heart rate; LT = lactate threshold; GET = gas exchange threshold
Table
Table 4 Possible Effects of Exercise in Cystic Fibrosis
Parameter Effects Comments References
Cardio-Pulmonary System Improved lung function and decelerate 
decline in lung function (FEV1; FVC) over 
3 years. Partially improved FVC and TLC.
Effects of exercise on lung function are only verifiably in some 
training studies in CF. Longitudinal and controlled studies would 
be desirable to confirm possible effects. 
15;67-69
Increased inspiratory muscle strength and 
endurance.
70-72
Enhanced sputum clearance in the airways, 
improved EV and lower breathlessness.
Exercise in combination with physiotherapy may have the best 
effects.
14;53;69-71
Improved aerobic fitness ( 2OV max) and 
reduced HR at rest and submaximal 
exercise levels.
After completion of training, improvements will drop back to 
baseline level. 
1;15;53;70
Strength Increased anaerobic power, muscle 
strength, and muscle size.
Strength was measured using different methods: Wingate Test; 
isokinetic dynamometer; manual muscle testing techniques and 
circumference measures or one repetition maximum weight lifts. 
13;15;16;52
Body Composition Increased FFM, weight gain respectively 
weight stabilization after training.
Bone health?
Unfortunately, there have been no controlled intervention studies 
investigating the effects of training on bone mass and bone density, 
whereas studies have shown that children with CF are able to 
perform high intensity exercises. Investigators found higher levels 
of PA and energy expenditure associated with higher BMD in CF.
73-75
Quality of Life Improved QoL and psychological status 
(less anxiety and depression scores).
Higher degree of perceived confidence and
self-esteem.
Higher habitual activity is correlated with higher QoL in CF. 1;11;12;67;76
Life Expectancy Patients with higher 2OV max values may 
have a greater life expectancy and a more 
slowly progressive disease.
Higher levels of aerobic fitness have shown to be associated with a 
significantly lower risk of dying, whereas patients with high 
aerobic fitness were more than 3 times likely to survive. 
4
FEV1 = forced expiratory volume in 1s; FVC= forced vital capacity; TLC= total lung capacity; EV = minute ventilation; 2OV max = maximal oxygen consumption; HR = 
heart rate; FFM = fat free mass; PA = physical activity; BMD = bone mineral density; QoL = quality of life.
Table
